Transgenic lambda medaka as a new model for germ cell mutagenesis.
To address the need for improved approaches to study mutations transmitted to progeny from mutagen-exposed parents, we evaluated lambda transgenic medaka, a small fish that carries the cII mutation target gene, as a new model for germ cell mutagenesis. Mutations in the cII gene in progeny derived from ethyl-nitrosourea (ENU)-exposed males were readily detected. Frequencies of mutant offspring, proportions of mosaic or whole body mutant offspring, and mutational spectra differed according to germ cell stage exposed to ENU. Postmeiotic germ cells (spermatozoa/late spermatids) generated a higher frequency of mutant offspring (11%) compared to premeiotic germ cells (3.5%). Individuals with cII mutant frequencies (MF) elevated more than threefold above the spontaneous MF (3 x 10(-5)) in the range of 10(-4) to 10(-3) were mosaic mutant offspring, whereas those with MFs approaching 1 x 10(-2) were whole body mutant offspring. Mosaic mutant offspring comprised the majority of mutant offspring derived from postmeiotic germ cells, and unexpectedly, from spermatogonial stem cells. Mutational spectra comprised of two different mutations, but at identical sites were unusual and characteristic of delayed mutations, in which fixation of a second mutation was delayed following fertilization. Delayed mutations and prevalence of mosaic mutant offspring add to growing evidence that implicates germ cells in mediating processes postfertilization that contribute to genomic instability in progeny. This model provides an efficient and sensitive approach to assess germ cell mutations, expands opportunities to increase understanding of fundamental mechanisms of mutagenesis, and provides a means for improved assessment of potential genetic health risks.
Winn
Richard N
RN
Aquatic Biotechnology and Environmental Laboratory, Warnell School of Forestry and Natural Resources, University of Georgia, Athens, Georgia. rwinn@uga.edu
Majeske
Audrey J
AJ
Jagoe
Charles H
CH
Glenn
Travis C
TC
Smith
Michael H
MH
Norris
Michelle B
MB
D000818:Animals; D030801:Animals, Genetically Modified; D005038:Ethylnitrosourea / Q000633:toxicity*; D005854:Germ Cells / Q000187:drug effects*; D008297:Male; D023421:Models, Animal; D016296:Mutagenesis; D009153:Mutagens / Q000633:toxicity*; D009990:Oryzias / Q000235:genetics*; D014157:Transcription Factors / Q000235:genetics*; D014764:Viral Proteins / Q000235:genetics*
D009153:Mutagens; D014157:Transcription Factors; D014764:Viral Proteins; C039000:cII protein, bacteriophage lambda; D005038:Ethylnitrosourea